- Home
- MAX vs KURA Comparison
MAX vs KURA Comparison
Compare MAX & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAX | KURA |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.8M | 744.0M |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MAX | KURA |
|---|---|---|
| Price | $10.08 | $8.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | $14.58 | ★ $26.88 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 05-25-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.81 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,113,600,000.00 | $67,482,000.00 |
| Revenue This Year | $10.18 | $124.03 |
| Revenue Next Year | $10.51 | $28.63 |
| P/E Ratio | $26.54 | ★ N/A |
| Revenue Growth | ★ 28.78 | 25.24 |
| 52 Week Low | $7.09 | $5.41 |
| 52 Week High | $13.92 | $12.49 |
Technical Indicators
Market Signals| Indicator | MAX | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 58.06 |
| Support Level | $9.47 | $8.09 |
| Resistance Level | $11.20 | $10.50 |
| Average True Range (ATR) | 0.51 | 0.39 |
| MACD | 0.34 | 0.09 |
| Stochastic Oscillator | 84.41 | 96.49 |
Price Performance
Historical ComparisonAbout MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.